Petrine Wellendorph

Søgeresultater

• 2024

  Ways of modulating GABA transporters to treat neurological disease

  Mortensen, J. S., Mikkelsen, A. N. L. & Wellendorph, P., 2024, I: Expert Opinion On Therapeutic Targets. 28, 7, s. 529-543

  Publikation: Bidrag til tidsskrift › Review › Forskning › peer review

  Åben adgang

  Fil
  3 Citationer (Scopus)

  1 Downloads (Pure)
• 2022

  CaMKIIα as a Promising Drug Target for Ischemic Grey Matter

  Griem-Krey, N., Clarkson, A. N. & Wellendorph, P., 2022, I: Brain Sciences. 12, 12, 21 s., 1639.

  Publikation: Bidrag til tidsskrift › Review › Forskning › peer review

  Åben adgang

  Fil
  5 Citationer (Scopus)

  23 Downloads (Pure)
• 2019

  Structural and molecular aspects of betaine-GABA transporter 1 (BGT1) and its relation to brain function

  Kickinger, S., Hellsberg, E., Frølund, B., Schousboe, A., Ecker, G. F. & Wellendorph, P., 2019, I: Neuropharmacology. 161, 14 s., 107644.

  Publikation: Bidrag til tidsskrift › Review › Forskning › peer review
  24 Citationer (Scopus)
• 2014

  GHB receptor targets in the CNS: Focus on high-affinity binding sites

  Bay, T., Eghorn, L. F., Klein, A. B. & Wellendorph, P., 2014, I: Biochemical Pharmacology. 87, 2, s. 220-228 9 s.

  Publikation: Bidrag til tidsskrift › Review › Forskning › peer review
  95 Citationer (Scopus)